Arjun Mn
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Arjun Mn has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Abhishek Kumar
Department of Rheumatology, Command Hospital, Kolkata, West Bengal, India
1 shared publication - Ajay Sebastian Carvalho
Command Hospital Eastern Command, Kolkata, India
1 shared publication - Arun Hegde
Department of Medicine and Rheumatology, Military Hospital , Belagavi, Karnataka
1 shared publication - Ashok Kumar
Associate Professor, PG Department of Shalya Tantra, NIA, Jaipur, India
1 shared publication - D. S. Bhakuni1 shared publication
- Kavita Singh
Heidelberg Institute of Global Health, Heidelberg University Hospital and Medical Faculty, Im Neuenheimer Feld 130.3, 69120, Heidelberg, Germany.
1 shared publication
Latest Publications
- Open Access
- 1 January 2022
- Published by AVES YAYINCILIK A.Ş. in European Journal of Rheumatology
- Vol. 9 (1) , 26-30
Serum interleukin-6 in seropositive rheumatoid arthritis and response to tocilizumab: An observational study
Objective: There is no clinically useful biomarker as a predictor of response to any class of biological disease-modifying antirheumatic drugs (bDMARD). Serum interleukin-6 (IL-6) has a major role in the pathogenesis of rheumatoid arthritis (RA) and its serum level in patients of RA may predict response to treatment with IL-6 receptor (IL-6R) antagonist tocilizumab. Methods: Biological DMARD naïve patients of seropositive RA, fulfilling American College of Rheumatology/European League Against Rheumatism classification criteria 2010, were treated with 06 doses of tocilizumab (8mg/kg) at monthly interval. Baseline and post-treatment serum IL-6 levels were measured and correlated with response to treatment measured by disease activity score-28 joints erythrocyte sedimentation rate (DAS28 ESR) after treatment. Results: The study included 34 patients and 26 (70%) of them achieved DAS-28 remission (DAS28 ESR < 2.6). The baseline serum IL-6 did not correlate with post-treatment DAS28 ESR (R −0.197, P = .264). Though, statistically not significant (P = .085) more patients with comparatively lower baseline serum IL-6 attained DAS28 remission (16 out of 17, P = .085). There was an increase in the serum IL-6 level (median 40.5pg/ml [IQR 130.2] to 72.6pg/ml [IQR 162.5]) after tocilizumab treatment and the change in IL-6 level also did not correlate with post-treatment DAS28 ESR (R −0.240, P = .172). Conclusion: Higher number of patients with comparatively lower serum IL-6 level attained DAS28 remission in this study; however, it was not statistically significant. It requires further evaluation in larger studies to make any conclusion on the role of serum IL-6 as a predictor of response to tocilizumab in seropositive RA. Cite this article as: Kumar A, Bhakuni DS, Kartik S, et al. Serum interleukin-6 in seropositive rheumatoid arthritis and response to tocilizumab: An observational study. Eur J Rheumatol. 2021;9(1):26-30.
- 1 January 2022
- Published by AVES YAYINCILIK A.Ş. in European Journal of Rheumatology
- Vol. 9 (1) , 26-30
Open AccessSerum interleukin-6 in seropositive rheumatoid arthritis and response to tocilizumab: An observational study
Objective: There is no clinically useful biomarker as a predictor of response to any class of biological disease-modifying antirheumatic drugs (bDMARD). Serum interleukin-6 (IL-6) has a major role in the pathogenesis of rheumatoid arthritis (RA) and its serum level in patients of RA may predict response to treatment with IL-6 receptor (IL-6R) antagonist tocilizumab. Methods: Biological DMARD naïve patients of seropositive RA, fulfilling American College of Rheumatology/European League Against Rheumatism classification criteria 2010, were treated with 06 doses of tocilizumab (8mg/kg) at monthly interval. Baseline and post-treatment serum IL-6 levels were measured and correlated with response to treatment measured by disease activity score-28 joints erythrocyte sedimentation rate (DAS28 ESR) after treatment. Results: The study included 34 patients and 26 (70%) of them achieved DAS-28 remission (DAS28 ESR < 2.6). The baseline serum IL-6 did not correlate with post-treatment DAS28 ESR (R −0.197, P = .264). Though, statistically not significant (P = .085) more patients with comparatively lower baseline serum IL-6 attained DAS28 remission (16 out of 17, P = .085). There was an increase in the serum IL-6 level (median 40.5pg/ml [IQR 130.2] to 72.6pg/ml [IQR 162.5]) after tocilizumab treatment and the change in IL-6 level also did not correlate with post-treatment DAS28 ESR (R −0.240, P = .172). Conclusion: Higher number of patients with comparatively lower serum IL-6 level attained DAS28 remission in this study; however, it was not statistically significant. It requires further evaluation in larger studies to make any conclusion on the role of serum IL-6 as a predictor of response to tocilizumab in seropositive RA. Cite this article as: Kumar A, Bhakuni DS, Kartik S, et al. Serum interleukin-6 in seropositive rheumatoid arthritis and response to tocilizumab: An observational study. Eur J Rheumatol. 2021;9(1):26-30.
- Open Access
- 27 November 2020
- Published by Nepal Journals Online (JOL) in Nepal Journal of Neuroscience
- Vol. 17 (3) , 12-16
Predictive Factors of Inadvertent Durotomy in Lumbosacral Prolapsed Intervertebral Disc Surgeries: A Retrospective Review at a Tertiary Care Centre in India
Introduction: Inadvertent dural tear is an undesirable intraoperative complication of spine surgery, with a reported incidence range of 1.7% to 17%. The purpose of this study is to determine the predictive factors of inadvertent durotomies (ID) in lumbosacral prolapsed disc surgeries and suggest a scoring system for pre-operative assessment of these predictors. Methods and Materials: This is a retrospective observational study done in 230 patients operated for prolapsed lumbar intervertebral discs, between January 2010 to November 2012. The inadvertent dural tears were grouped as unrecognised, simple and complicated. Data were collected regarding diagnosis, comorbidities, surgical procedure, operating surgeon, prior spine surgeries, type of ID and complications. Results: Of the 230 patients, ID was seen in 6.5 % (15 patients). Higher incidences were noted in elderly (33.3%) and obese (7.6%). Bone nibbler and Kerrison’s rongeur were the most common tools associated. Redo surgeries have a significant higher incidence (12.9%) as compared to the first surgery (5.53%). Conclusions: The risk of ID in prolapsed lumbar intervertebral disc surgeries is high in presence of bony and ligamentous canal stenosis, instrument handling, and in smaller size of incisions. Additionally, elderly age of patients, obesity and surgeon fatigue appears to be a major determinant. Conscious effort to prevent this complication during surgery by predicting risks pre-operatively using a scoring system can aid in preventing ID.
- 27 November 2020
- Published by Nepal Journals Online (JOL) in Nepal Journal of Neuroscience
- Vol. 17 (3) , 12-16
Open AccessPredictive Factors of Inadvertent Durotomy in Lumbosacral Prolapsed Intervertebral Disc Surgeries: A Retrospective Review at a Tertiary Care Centre in India
Introduction: Inadvertent dural tear is an undesirable intraoperative complication of spine surgery, with a reported incidence range of 1.7% to 17%. The purpose of this study is to determine the predictive factors of inadvertent durotomies (ID) in lumbosacral prolapsed disc surgeries and suggest a scoring system for pre-operative assessment of these predictors. Methods and Materials: This is a retrospective observational study done in 230 patients operated for prolapsed lumbar intervertebral discs, between January 2010 to November 2012. The inadvertent dural tears were grouped as unrecognised, simple and complicated. Data were collected regarding diagnosis, comorbidities, surgical procedure, operating surgeon, prior spine surgeries, type of ID and complications. Results: Of the 230 patients, ID was seen in 6.5 % (15 patients). Higher incidences were noted in elderly (33.3%) and obese (7.6%). Bone nibbler and Kerrison’s rongeur were the most common tools associated. Redo surgeries have a significant higher incidence (12.9%) as compared to the first surgery (5.53%). Conclusions: The risk of ID in prolapsed lumbar intervertebral disc surgeries is high in presence of bony and ligamentous canal stenosis, instrument handling, and in smaller size of incisions. Additionally, elderly age of patients, obesity and surgeon fatigue appears to be a major determinant. Conscious effort to prevent this complication during surgery by predicting risks pre-operatively using a scoring system can aid in preventing ID.